Clinical trial
Trial to Assess the Effectiveness of Maintaining Patency and Safety of the Vascular Wrap Paclitaxel-Eluting Mesh After Surgical Implantation With the Lifespan® ePTFE Vascular Graft in the Upper Extremity for Hemodialysis Vascular Access
NCT00448708 is registered in ClinicalTrials.gov with Angiotech Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Trial to Assess the Effectiveness of Maintaining Patency and Safety of the Vascular Wrap Paclitaxel-Eluting Mesh After Surgical Implantation With the Lifespan® ePTFE Vascular Graft in the Upper Extremity for Hemodialysis Vascular Access
- Lead sponsor
- Angiotech Pharmaceuticals
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- March 31, 2007
- Completion date
- April 30, 2009
- Enrollment
- 222 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.
esrd, kidney diseases